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ABSTRACT 
Ocular gene transfer may provide a means for arresting the retinal degeneration characteristic of many in-
herited causes of blindness, including retinitis pigmentosa (RP). Previously, w e have shown in immunodefi-
cient animals that recombinant adeno-associated virus (rAAV) mediates transduction of photoreceptors as 
well as the retinal pigment epithelium (RPE) following subretinal injection. In this study w e extend these ob-
servations and show that highly purified recombinant A A V vectors encoding the reporter gene LacZ trans-
duce photoreceptors in an immunocompetent mouse strain following subretinal injection and efficiently trans-
duce ganglion cells after intravitreal injection. Levels of transduction increase over time. Sublethal 
y-irradiation is shown to facilitate this process. 
INTRODUCTION 
RETINITIS PIGMENTOSA is onc of the most common inherited 
eye disorders, affecting approximately I in 3,500 of the 
general population and causing progressive blindness. These 
diseases are characterized by peripheral retinal degeneration 
with loss of rods and subsequentiy cone cells leading to loss of 
central vision. At least 30 mapped loci have been directly as-
sociated with RP. Seven different nonsyndromic RP genes have 
been identified to date, five of which are expressed exclusively 
in photoreceptor cells (Dryja et al, 1990, 1995; Farrar et al, 
1991; McLaughlin et al, 1993; Bascom et al, 1995). At pres-
ent, tteattnent that will retard or prevent the onset of blindness 
is not available. However, transfer of a normal copy of the de-
fective gene to diese cells may arrest the degenerative process 
and preserve vision to a degree relating to maturity of die dis-
ease process. The photoreceptor layer appears to be most ac-
cessible to gene ttansfer by subretinal injection. However, ex-
perience obtained with adenovims-based delivery systems 
suggests diat transduction of photoreceptors is relatively mef-
ficient, particularly in adult animals (Bennett et al, 1994; Li et 
al, 1994; Mashour etal, 1994). An altemative treatinent sttat-
egy for RP might be to delay photoreceptor degeneration by in-
creasing the intraocular levels of neurotrophic factors. This 
sttategy does not rely on ttansduction of neuroretina. Secreted 
neurotrophic factors could be produced by any ttansduced cell. 
The number of transduced retinal pigment epithelium (RPE) 
cells following subretinal injection of adenovims and the num-
ber of transduced cells in the anterior segment (ciliary body, 
iris, ttabecular meshwork, and comeal endothelium) following 
inttavitreal injection is much greater than the number of cells 
ttansduced in the neuroretina (Ali et al, 1997). Recent data sug-
gest that adenovims-mediated expression of ciliary neu-
rottophic factor, after inttavitteal injection of vims, is able to 
delay retinal degeneration in the rd mouse, an animal model of 
RP (Cayouette and Gravel, 1997). The effectiveness of this ap-
proach, however, may be limited by the toxicity of adenovims 
at high multiplicities of infection (Li et al, 1994), and by im-
mune responses directed against vttal genes expressed from the 
vector backbone (manuscript in preparation). 
Adeno-associated vims (AAV) is a nonpathogenic human 
parvovims that has atttacted considerable interest as a gene 
ttansfer vector (Kotin, 1994). Replication of this vims is usu-
ally dependent on co-infection with a helper vims. In the ab-
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sence of helper vims (usually adenovims) the wild-type A A V 
genome can integrate stably into the host cell genome by non-
homologous recombination, usually in a tandem head-to-tail 
orientation. Analysis of flanking sequences from latentiy in-
fected human cells has shown that integration occurs at multi-
ple sites within a single specific locus (AAVSl) in 60-70% of 
cases, which maps to human chromosome 19ql3.3-qter. A A V 
vectors in which the rep gene is deleted probably integrate ran-
domly, suggesting that rep gene products (Rep78 and Rep68) 
are important for this process (Kumar and Leffak, 1991; Keams 
et al, 1996; Ponnazhagan et al, 1997). Vectors based on A A V 
may offer considerable advantages with respect to toxicity and 
immune response because they are deleted for all virally en-
coded proteins. In some tissues, transduction appears to be lim-
ited by inefficient conversion of the incoming single-stranded 
D N A genome to a transcriptionally active double-stranded tem-
plate (Fisher et al, 1996; Ferrari et al, 1996). This process can 
be facilitated by co-infection with adenovims through expres-
sion of the early gene product E4 orf6 or herpes vimses and 
some of their derivative vectors (unpublished results). Similar 
increases in ttansduction efficiency have been reported after 
treatment of cultured cells with y-irradiation and topoisomerase 
inhibitors, and more recently after y-irradiation in vivo (Alexan-
der et al, 1994; Russell et al, 1995; Koeberi et al, 1997). The 
mechanism of this process is undetermined, but may involve 
upregulation of D N A repair enzyme activity. 
W e have previously shown that rAAV vectors encoding the 
reporter gene LacZ efficiendy ttansduce the R P E and are more 
efficient at transducing the neuroretina than A V vectors (Ali et 
al, 1996). This is consistent with recent data that support the 
utility of this vector system for transduction of post-mitotic neu-
ronal and muscle cells (Kapplitt et al, 1994; Xiao et al, 1996; 
Kessler era/., 1996; Zolotukbin era/., 1996; Fisher e? a/., 1997). 
W e now extend our original observations, and show that levels 
of ttansduction increase over a period of time, and that this 
process can be augmented in vivo by sublethal doses of y-irra-
diation. 
MATERIALS AND METHODS 
Vectors and production of recombinant viruses 
pTRCMV/3 (gift from N. Muzyczka) consists of a LacZ re-
porter gene, cytomegalovims ( C M V ) immediate-eariy pro-
moter-enhancer, late gene 16S/19S splice donor/splice accep-
tor signal, and a heterologous polyadenylation signal. This 
cassette is flanked by 165-bp terminal repeat sequences de-
rived from the wild-type A A V genome. pcpSRepCap was con-
stmcted by cloning a Bai I fragment containing both rep and 
cap genes into pcDNA3 (Invitrogen) deleted for the C M V pro-
moter. The SV40 origin in this vector permits episomal repli-
cation in cell lines expressing the SV40 large T antigen. Re-
combinant viral particles were produced as previously 
pubhshed (Chiorini, 1995). Twenty confluent 150-mm plates 
of COS-7 (ATCC CRL1651) cells were trypsinized and sus-
pended at a cell concentration of 2 X 10^/ml in 100% RPMI, 
2 0 % heat-inactivated fetal calf semm (FCS). Five hundred mi-
croliters of cell suspension was placed in an electroporation 
cuvette (Biorad) with 30 ^ ig of pTRCMV/3 and 30 pg pcRep-
Cap and incubated on ice for 10 min. Cells were mixed gen-
tiy, pulsed in a BioRad gene pulser (960 pF, 250 V ) , and re-
tumed to ice for a further 10 min. Contents of all cuvettes were 
resuspended in Dulbecco's modified Eagle's medium 
( D M E M ) with 1 0 % FCS and antibiotics, and replated in ten 
150-mm dishes. Dead cells were removed the next day, and 
after a further 24 hr, wtAd5 was added to the plates in a total 
volume of 6 ml of D M E M at a multiplicity of infection (moi) 
of 5-10). Forty-eight hours later, at completion of the cyto-
pathic process, cells were harvested and pelleted by centrifu-
gation. The pellet was resuspended in T D buffer (140 m M 
NaCl, 5 m M KCl, 0.7 m M K2HPO4, 25 m M Tris HCl p H 7.4), 
and lysed with 500 pl of 0.25% trypsin and 500 pl of 1 0 % 
sodium deoxycholate per 7.5 ml of T D suspension. A A V vec-
tor stocks were purified from sequential caesium chloride gra-
dients, dialyzed against HEPES-buffered saline, concentrated 
by ultrafiltration (Microcon 30), and heated to 56°C for 20 min 
to inactivate residual adenovims. Infectious titer was deter-
mined by co-infection of HeLa cells with wtAd5 at a moi of 
5. Purity of viral stocks was confirmed by electron microscopy 
and by absence of cytopathic effect on HeLa cells. 
Intraocular injections 
Mice were anesthetized by inttaperitoneal (i.p.) injection of 
0.2 ml Hypnorm (Janssen Pharmaceutical Ltd, Oxford), and 
Hypnovel (Roche, Welwyn Garden City) mixed 1:1:6 with dis-
tilled water. Following dilation with 1 % Tropicamide (1% My-
driacyl, Alcon Labs, Watford), the eyes were protmded by gen-
tie pressure on the animal's mandible. Once the eye was 
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FIG. 1. AAV-mediated ttansduction after subretinal injection 
increases with time and is enhanced by y-irradiation. Trans-
duction efficiency of A A V following subretinal injection was 
scored after X-Gal incubation of the whole eye cup and exam-
ination under a dissecting microscope. The scores were assigned 
on the following basis: a score of 0 was given to eyes in which 
no blue staining was observed; a score of 1 was given to eyes 
in which there was a minimal staining; a score of 2 was given 
to eyes with a medium elvel of staining; and a score of 3 given 
to eyes with the most staining. The effects of sublethal irradi-
ation on transduction efficiency 4 weeks after injection is also 
shown. Data from 46 animals (92 eyes) is shown: 12 eyes were 
analyzed at each point except at 12 weeks, when 8 eyes were 
scored. Error bars represent SD. 
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FIG. 2. Macroscopic photographs showing eyes taken from 
BALB/c mice at 2 weeks (A) and 6 weeks (B) following sub-
retinal injection of AAV.LacZ. The eyes were prefixed in 
paraformaldehyde and the comea, iris, and lens removed be-
fore ovemight incubation in X-Gal. The density of blue stain-
ing increases substantially over time. 
proptosed, it was held in this position by a mbber sleeve that 
was placed around the eye with a pair of forceps. The proce-
dure is best described by analogy with a button hole, in which 
the mbber sleeve is the button hole and the mouse eye the but-
ton. It was held in position by the sleeve, which has a slit in 
the center to fit the eye. The pressure of the mbber sleeve on 
the eye was always moderate and did not block the circulation. 
Using this technique made fixation with ocular muscle sutures 
unnecessary. 
Subsequently, the eye was covered with 2 % hypromellose 
(methylcellulose) in saline and a small cover slip was fitted. 
This allowed surgery to be performed under direct rhinoscopy 
thorough an operating microscope. The tip of a 1.5-cm, 34-
gauge hypodermic needle (Hamilton, Switz) was guided in be-
tween the coverslip and the mbber sleeve to the sclera of the 
mouse eye and then injected tangentially through it causing a 
self-sealing wound tunnel. The needle tip was brought into fo-
cus between the retina and RPE and approximately 2 pl of vi-
ral stock was injected to produce a retinal detachment. For in-
jection into the vitteous, the eye was protruded using a mbber 
sleeve and additionally stabilized by holding an exttaocular 
muscle with a patt of fine forceps. The 34-gauge needle was 
injected through the comea and iris in close proximity to the 
FIG. 3. A and B. Wax sections of 10 p m through retinas 6 
weeks after subretinal injection reveal transduced RPE cells as 
well as transduced photoreceptor cells (counterstained with Nu-
clear Fast Red; 25X and 50x objectives). C. A 6-pm wax sec-
tion through the retina, 6 weeks after inttavitteal injection, 
showing transduced ganglion cells as well as an occasional 
transduced cell in the inner nuclear layer (counterstained with 
Nuclear Fast Red, 50X objective). 
limbus of the mouse eye. To avoid the large lens, the needle 
was guided parallel to the sclera before being dttected into the 
vitteous behind the lens. Two microliters of viral suspension 
was injected once the needle tip could be seen in the vitteous 
cavity behind the lens. All of the mice were BALB/c (Harlan 
Olac Ltd., Bicester). A total of 54 animals underwent this pro-
cedure and they were 4—8 weeks old at time of injection. Six 
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mice received single-dose sublethal y-irradiation (5 Gy, Gam-
macell 1000) 24 hr after injection. 
X-Gal staining and histology 
Animals were killed by cervical dislocation and the enucle-
ated eyes were prefixed by immersion in 1 0 % buffered forma-
lin for 45 min. The comea and lens were separated from the 
eye cups and then all were rinsed in phosphate-buffered saline 
(PBS) and incubated ovemight at room temperature with X-
Gal (5-bromo-4-chloro-3-indolyl-/3-D-galactopyranoside; Cal-
biochem, La Jolla, C A ) in a solution containing 10 m M 
K3Fe(CN)6, 10 m M K4Fe(CN)6, 2 m M M g C b , in PBS. After 
incubation with X-Gal, the eyes were examined under a dis-
secting microscope to enable the proportion of transduced retina 
to be scored. The tissue was then fixed in 1 0 % neutral buffered 
formalin, embedded in paraffin, and sectioned at a thickness of 
5-10 pm. Sections were counterstained with Nuclear Fast Red 
and examined by light microscopy. 
RESULTS AND DISCUSSION 
Previously, we have demonsttated that after subretinal in-
jection, A A V is up to 2,000-fold more efficient than A V at 
ttansducing photoreceptor cells (Ali et al, 1996). In these ex-
periments, we consistentiy failed to see gene expression at early 
time points after injection. Using nude mice to eliminate the ef-
fect of immune responses against viral gene or transgene prod-
ucts, we could demonstrate ttansduction of RPE and photore-
ceptor cells after 28 days. W e have now repeated these 
experiments in immunocompetent mice using highly purified 
r A A V preparations free from contaminating adenovirus (see 
Materials and Methods). 
The A A V vector consists of a C M V immediate-early pro-
moter, and LacZ reporter gene (pTRCMV/3, obtained from N. 
Muzyczka). Highly purified recombinant A A V (10* infectious 
particles) was injected in a total volume of 2 pl either by sub-
retinal or intravitreal injection into 4- to 8-week-old immuno-
competent BALB/c mice. At weekly time points after subreti-
nal injection, mice were sacrificed and enucleated. W e observed 
a gradual increase in the number of ttansduced cells in the outer 
retina over time (Fig. 1). Although there was some variability 
in levels of transduction between different animals, which may 
reflect the difficulty of precise injections, or variable degrees 
of tissue damage incurred during this process, there was clearly 
much greater transduction after 6 weeks than after 2 weeks post-
injection (Fig. 2A,B). Eight eyes from 4 animals were still pos-
itive 3 months after subretinal injection (data not shown). W e 
found no evidence of inflammatory cell infiltration at any time 
point examined. After evaluation under the dissecting micro-
scope, eyes were embedded in paraffin wax and sectioned. 
Transduced cells consisted mostly of RPE cells with scattered 
photoreceptors (Fig. 3A,B). T w o weeks after injection, up to 
5 % of R P E cells were transduced in approximately one-quar-
ter of the retina—an area corresponding to the retinal detach-
ment. N o transduced photoreceptors were observed at this time 
point. After 6 weeks, up to 1 % of photoreceptors and 9 0 % of 
R P E cells were transduced in the area of detachment. The oc-
casional ttansduced cell was observed in the inner nuclear layer 
(data not shown). Inttavitreal injection of A A V resulted in dif-
fuse ttansduction, mostiy of the inner retina (Fig. 4A,B), which 
also increased with time. Here we compared ttansduction lev-
els 2 weeks and 6 weeks post injection. Upon sectioning, it was 
apparent that the transduced cells were mostiy ganglion cells 
(Fig. 3C). U p to 5 % of the ganglion cells throughout the retina 
were ttansduced 6 weeks after injection. W e also observed the 
occasional transduced cell in the inner nuclear layer (Fig. 3C) 
and the occasional transduced photoreceptor. The pattem of 
transduction after intravitteal injection of A A V is quite differ-
ent from that seen after inttavitteal injection of adenovims. Fol-
lowing intravitreal injection of A A V , almost all of the ttans-
duced cells are in the inner retina, whereas after inttavitteal 
injection of adenovims, the majority of ttansduced cells are 
found in the non-neural cells of the anterior segment (see In-
troduction). The reasons for this are not clear. 
Transduction by A A V vectors has been shown to be facili-
tated by administration of DNA-damaging agents both in vitro 
and in vivo. Eight mice were therefore uijected after receiving 
sublethal whole-body y-irradiation (5 Gy) from a cesium 
source. Compared with four nonirradiated controls, levels of 
transduction at 4 weeks were significandy enhanced (Fig. I and 
5A,B). Although there was more uniform ttansduction, the 
treatment did not alter the proportion of ttansduced photore-
ceptor cells relative to transduced RPE. 
Inherited diseases of the retina and the R P E are good can-
didates for therapies based on gene ttansfer because of the ac-
cessibility of the target tissues. In our hands, ttansduction of 
photoreceptor cells by adenoviral vectors has been inefficient, 
associated with toxicity at high moi, and with immunogenicity 
against proteins expressed from the vector backbone. These lat-
est studies reinforce our previous observations that A A V vec-
tors may have utility for therapeutic gene ttansfer to neuroreti-
nal cells. The increase in ttansduction over time mirrors 
previous studies in vitro and in vivo, and suggests that host cell 
mechanisms are able to convert incoming vector genomes to 
transcriptionally active templates in the absence of co-infecting 
helper vims. W e have also shown that prior administtation of 
sublethal doses of y-irradiation facilitates this process, although 
it is unclear whether this reflects induction of host cell repatt 
polymerase activity or facilitated recmitment to the nuclear 
transcriptional machinery (Ferrari et al, 1996; Fisher et al., 
1996; Weitzman et al, 1996). It is unlikely that die immuno-
suppressive effects of the tteatment were responsible for the en-
hanced expression because we could eventually detect high-
level expression after several months in nonttradiated 
immunocompetent animals. Tissue damage incurred at die site 
of subretinal injection could also enhance ttansduction, al-
though the efficacy of intravitteal injection suggests diat this is 
not a prerequisite for gene expression. 
Removal of all virus-encoded genes from the vector back-
bone is beneficial to the packaging capacity of die vims, and 
possibly to its immunogenicity, but may be detrimental to the 
process by which wild-type A A V establishes latent infection. 
It is likely that vectors deleted for A A V rep integrate randomly. 
Although we have not examined the frequency of integration 
of the vector genome, recent studies in which r A A V particles 
were injected into post-mitotic muscle tissue demonsttate the 
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FIG. 4. A and B. Macroscopic photographs showing punc-
tate X-Gal-positive staining in the posterior eye cups taken from 
BALB/c mice at 6 weeks following intravitreal injection of 
AAV.LacZ. The eyes were prefixed in paraformaldehyde and 
the comea, iris, and lens removed before ovemight incubation 
in X-Gal. 
FIG. 5. Transduction of the retina by A A V is substantially 
enhanced by whole-body irradiation. The macroscopic pho-
tographs show eyes taken from BALB/c mice at 4 weeks fol-
lowing subretinal injection of AAV.LacZ. The eyes were pre-
fixed in paraformaldehyde and the comea, iris, and lens 
removed before ovemight incubation in X-Gal. A shows an eye 
from a nonirradiated control animal. B shows an eye from 
mouse that received sublethal y-irradiation (5 Gy) 24 hr after 
injection. 
formation of head-to-tail or tail-to-tail tandem arrays consistent 
with genomic integration (Xiao et al, 1996; Fisher et al, 1997). 
A similar mechanism may, in part, explain the stability of pho-
toreceptor transduction seen in this study and is currently un-
der investigation. Particularly impressive is the lack of an im-
mune response to the transduced cells, which is in contrast to 
our experience using first-generation El-deleted adenoviral 
vectors. Paucity of immune responses against the vector and re-
porter ttansgene in the context of A A V probably contribute to 
the stability of transduction. 
Future smdies will focus on the administration of therapeu-
tic genes to murine models of RP. However, the rapidity with 
which ttreversible retuial degeneration becomes established in 
these models may require the kinetics of ttansduction by A A V 
vectors to be facilitated. This process is now under investiga-
tion. Although y-UTadiation accelerates AAV-mediated gene 
ttansduction in murine models, human retinal degeneration is 
progressive over long periods of time so that some delay in gene 
expression is unlUcely to prevent therapeutic efficacy. 
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